Clinical Trial Update: Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

View source ↗

Summary

An NCI-sponsored clinical trial evaluating Von Hippel-Lindau–associated renal and other urologic malignancies, including manifestations, diagnosis, management, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Familial Renal Cancer
• Kidney Cancer
• Renal Cell Carcinoma
• Von Hippel-lindau Disease

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer, Urologic Malignant Disorders | Status: RECRUITING